Back to Annual Meeting
Back to Annual Meeting
APHA Scientific Session and Event Listing
Session: Improving Access to Essential Drugs
3325.0: Monday, November 06, 2006: 2:30 PM-4:00 PM
Improving Access to Essential Drugs
A small number of essential medicines consistently available has been shown to have a significant impact on health outcomes. However maintaining access to essential medicines is an enormous challenge. Pricing issues, supply chain issues, broader drug management, prescribing practices, and quality of drugs all affect access. In this session we look at different aspects of establishing national and program specific drug supply mechanisms. In Timor Leste we look at a post conflict situation where systems did not exist. On a programmatic basis we look at how we can improve access to effective malaria case management, and then we go on to look at the specific issues relate to antiretroviral therapy.
Learning Objectives: Refer to the individual abstracts for learning objectives
Moderator(s):Jonathan D. Quick, MD, PhD
2:30 PMNegotiating Antiretroviral Drug Prices to Increase Access: The Experience of the Andean Countries  [ Recorded presentation ]
Rosa Rodriguez-Monguio, PhD, Enrique C. Seoane Vazquez, PhD
2:50 PMStarting from Scratch: Establishing Pharmaceutical Supply in Timor-Leste  [ Recorded presentation ]
Maggie Huff-Rousselle, MA, MBA, PhD
3:10 PMImproving access to essential medicines for effective malaria case management in endemic countries
Rima Shretta, MSc
3:30 PMBuilding Systems to Support ART Scale-Up: Creating Health Management Information System to Support ART Service Delivery in Zambia and Kenya  [ Recorded presentation ]
James C. Setzer, MPH, Gilbert Kombe, MD, MPH, Paul S. Chishimba, Catherine B. Decker
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:International Health
Endorsed by:HIV/AIDS; Medical Care; Socialist Caucus
CE Credits:CME, Health Education (CHES), Nursing

The 134th Annual Meeting & Exposition (November 4-8, 2006) of APHA